Department of Gastroenterology, Hiraka General Hospital, Japan.
Intern Med. 2021 May 15;60(10):1493-1499. doi: 10.2169/internalmedicine.6020-20. Epub 2020 Dec 15.
Objective In an effort to reduce mortality from gastric cancer, endoscopic screening was introduced in 2016 as a nationwide screening program in Japan. Recent developments in high-definition endoscopic imaging and diagnostic strategies have enabled the simultaneous detection of other upper gastrointestinal (U-GI) malignancies. Therefore, we conducted a study to evaluate the feasibility of endoscopic screening for U-GI malignancy in a comprehensive health checkup. Methods We retrospectively reviewed the data of 13,120 participants who had received a comprehensive health checkup in a single institution between April 2012 and March 2018. Participants were divided into two groups [gastrointestinal endoscopy (GIE) group (n=9,142) and gastrointestinal X-ray (X-ray) group (n=3,978)] and compared with regards to the screening results, adverse events, and detection rate of U-GI malignancies (gastric cancer or other) using a propensity-score matched analysis. Results The gastric cancer detection rate was significantly higher in the GIE group [34/9,142 (0.48%)] than in the X-ray group [3/3,978 (0.08%)] (p=0.003). Other U-GI malignancies were found only in the GIE group and comprised two hypopharyngeal cancers, five esophageal cancers, two duodenal cancers, and one duodenal gastrointestinal stromal tumor. Adverse events occurred in 6/9,142 (0.07%) participants in the GIE group and 18/3,978 (0.45%) participants in the X-ray group (p<0.0001). A propensity-score matched analysis yielded 1,551 matched pairs, and the detection rate of gastric cancer and other U-GI malignancies remained significantly higher in the GIE group than in the X-ray group. Conclusion This study indicated that not only gastric cancer but also other U-GI malignancies can be detected by endoscopic screening.
为降低胃癌死亡率,日本于 2016 年启动了全国范围的内镜筛查计划。近年来,高清内镜成像和诊断策略的发展使得同时检测其他上消化道(U-GI)恶性肿瘤成为可能。因此,我们进行了一项研究,以评估在综合健康检查中进行 U-GI 恶性肿瘤内镜筛查的可行性。
我们回顾性分析了 2012 年 4 月至 2018 年 3 月期间在一家机构接受综合健康检查的 13120 名参与者的数据。参与者被分为两组[胃肠内镜(GIE)组(n=9142)和胃肠 X 射线(X 射线)组(n=3978)],并通过倾向评分匹配分析比较了两组的筛查结果、不良事件以及 U-GI 恶性肿瘤(胃癌或其他)的检出率。
GIE 组的胃癌检出率明显高于 X 射线组[34/9142(0.48%)](p=0.003)。其他 U-GI 恶性肿瘤仅在 GIE 组中发现,包括 2 例下咽癌、5 例食管癌、2 例十二指肠癌和 1 例十二指肠胃肠道间质瘤。GIE 组的 6/9142(0.07%)名参与者发生了不良事件,X 射线组的 18/3978(0.45%)名参与者发生了不良事件(p<0.0001)。通过倾向评分匹配分析得到 1551 对匹配对,GIE 组的胃癌和其他 U-GI 恶性肿瘤的检出率仍明显高于 X 射线组。
本研究表明,内镜筛查不仅可以检测胃癌,还可以检测其他 U-GI 恶性肿瘤。